Biden Admin. Working To Buy More Vaccine Doses

The video discusses the demand for COVID-19 vaccines and the challenges in meeting this demand due to production constraints. The Biden administration plans to purchase 200 million additional doses, split between Moderna and Pfizer, to vaccinate 300 million Americans by late summer or early fall. However, NPR analysis suggests that both companies need to double their production pace to meet deadlines. The manufacturing process is complex, with potential issues like equipment breakdowns and ingredient shortages, which could impact the ability to meet both US and international commitments.

What is the average number of doses that Moderna and Pfizer have been delivering weekly?

What factors could potentially disrupt the production of the vaccines?